nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—Ifosfamide—testicular cancer	0.0145	0.272	CbGbCtD
Cevimeline—CYP2D6—Vinblastine—testicular cancer	0.0121	0.227	CbGbCtD
Cevimeline—CYP3A4—Vinblastine—testicular cancer	0.0077	0.144	CbGbCtD
Cevimeline—CYP2D6—Doxorubicin—testicular cancer	0.00744	0.139	CbGbCtD
Cevimeline—CYP3A4—Etoposide—testicular cancer	0.00694	0.13	CbGbCtD
Cevimeline—CYP3A4—Doxorubicin—testicular cancer	0.00473	0.0885	CbGbCtD
Cevimeline—Haemorrhage—Methotrexate—testicular cancer	0.000422	0.000446	CcSEcCtD
Cevimeline—Pollakiuria—Doxorubicin—testicular cancer	0.000422	0.000446	CcSEcCtD
Cevimeline—Haematuria—Epirubicin—testicular cancer	0.00042	0.000443	CcSEcCtD
Cevimeline—Dizziness—Ifosfamide—testicular cancer	0.000419	0.000443	CcSEcCtD
Cevimeline—Pharyngitis—Methotrexate—testicular cancer	0.000419	0.000443	CcSEcCtD
Cevimeline—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000417	0.000441	CcSEcCtD
Cevimeline—Weight increased—Doxorubicin—testicular cancer	0.000416	0.000439	CcSEcCtD
Cevimeline—Epistaxis—Epirubicin—testicular cancer	0.000415	0.000439	CcSEcCtD
Cevimeline—Urethral disorder—Methotrexate—testicular cancer	0.000414	0.000437	CcSEcCtD
Cevimeline—Weight decreased—Doxorubicin—testicular cancer	0.000413	0.000437	CcSEcCtD
Cevimeline—Sinusitis—Epirubicin—testicular cancer	0.000413	0.000436	CcSEcCtD
Cevimeline—Feeling abnormal—Etoposide—testicular cancer	0.000413	0.000436	CcSEcCtD
Cevimeline—Hyperglycaemia—Doxorubicin—testicular cancer	0.000412	0.000435	CcSEcCtD
Cevimeline—Nausea—Dactinomycin—testicular cancer	0.000411	0.000434	CcSEcCtD
Cevimeline—Agranulocytosis—Epirubicin—testicular cancer	0.000411	0.000434	CcSEcCtD
Cevimeline—Pneumonia—Doxorubicin—testicular cancer	0.00041	0.000433	CcSEcCtD
Cevimeline—Gastrointestinal pain—Etoposide—testicular cancer	0.00041	0.000433	CcSEcCtD
Cevimeline—Visual impairment—Methotrexate—testicular cancer	0.000407	0.00043	CcSEcCtD
Cevimeline—Vomiting—Ifosfamide—testicular cancer	0.000403	0.000426	CcSEcCtD
Cevimeline—Hypersensitivity—Cisplatin—testicular cancer	0.000403	0.000426	CcSEcCtD
Cevimeline—Rash—Ifosfamide—testicular cancer	0.0004	0.000422	CcSEcCtD
Cevimeline—Dermatitis—Ifosfamide—testicular cancer	0.000399	0.000422	CcSEcCtD
Cevimeline—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000399	0.000422	CcSEcCtD
Cevimeline—Urticaria—Etoposide—testicular cancer	0.000398	0.00042	CcSEcCtD
Cevimeline—Haemoglobin—Epirubicin—testicular cancer	0.000397	0.00042	CcSEcCtD
Cevimeline—Stomatitis—Doxorubicin—testicular cancer	0.000397	0.000419	CcSEcCtD
Cevimeline—Rhinitis—Epirubicin—testicular cancer	0.000396	0.000419	CcSEcCtD
Cevimeline—Abdominal pain—Etoposide—testicular cancer	0.000396	0.000418	CcSEcCtD
Cevimeline—Body temperature increased—Etoposide—testicular cancer	0.000396	0.000418	CcSEcCtD
Cevimeline—Urinary tract infection—Doxorubicin—testicular cancer	0.000396	0.000418	CcSEcCtD
Cevimeline—Conjunctivitis—Doxorubicin—testicular cancer	0.000396	0.000418	CcSEcCtD
Cevimeline—Haemorrhage—Epirubicin—testicular cancer	0.000395	0.000418	CcSEcCtD
Cevimeline—Eye disorder—Methotrexate—testicular cancer	0.000395	0.000417	CcSEcCtD
Cevimeline—Tinnitus—Methotrexate—testicular cancer	0.000394	0.000416	CcSEcCtD
Cevimeline—Hypoaesthesia—Epirubicin—testicular cancer	0.000393	0.000415	CcSEcCtD
Cevimeline—Asthenia—Cisplatin—testicular cancer	0.000392	0.000414	CcSEcCtD
Cevimeline—Pharyngitis—Epirubicin—testicular cancer	0.000392	0.000414	CcSEcCtD
Cevimeline—Cardiac disorder—Methotrexate—testicular cancer	0.000392	0.000414	CcSEcCtD
Cevimeline—Oedema peripheral—Epirubicin—testicular cancer	0.000389	0.000411	CcSEcCtD
Cevimeline—Haematuria—Doxorubicin—testicular cancer	0.000388	0.00041	CcSEcCtD
Cevimeline—Urethral disorder—Epirubicin—testicular cancer	0.000387	0.000409	CcSEcCtD
Cevimeline—Epistaxis—Doxorubicin—testicular cancer	0.000384	0.000406	CcSEcCtD
Cevimeline—Angiopathy—Methotrexate—testicular cancer	0.000383	0.000405	CcSEcCtD
Cevimeline—Sinusitis—Doxorubicin—testicular cancer	0.000382	0.000404	CcSEcCtD
Cevimeline—Visual impairment—Epirubicin—testicular cancer	0.000381	0.000402	CcSEcCtD
Cevimeline—Agranulocytosis—Doxorubicin—testicular cancer	0.00038	0.000402	CcSEcCtD
Cevimeline—Chills—Methotrexate—testicular cancer	0.000379	0.0004	CcSEcCtD
Cevimeline—Nausea—Ifosfamide—testicular cancer	0.000377	0.000398	CcSEcCtD
Cevimeline—Diarrhoea—Cisplatin—testicular cancer	0.000374	0.000395	CcSEcCtD
Cevimeline—Alopecia—Methotrexate—testicular cancer	0.000373	0.000394	CcSEcCtD
Cevimeline—Eye disorder—Epirubicin—testicular cancer	0.000369	0.00039	CcSEcCtD
Cevimeline—Hypersensitivity—Etoposide—testicular cancer	0.000369	0.00039	CcSEcCtD
Cevimeline—Tinnitus—Epirubicin—testicular cancer	0.000368	0.000389	CcSEcCtD
Cevimeline—Malnutrition—Methotrexate—testicular cancer	0.000368	0.000388	CcSEcCtD
Cevimeline—Haemoglobin—Doxorubicin—testicular cancer	0.000368	0.000388	CcSEcCtD
Cevimeline—Flushing—Epirubicin—testicular cancer	0.000367	0.000387	CcSEcCtD
Cevimeline—Cardiac disorder—Epirubicin—testicular cancer	0.000367	0.000387	CcSEcCtD
Cevimeline—Rhinitis—Doxorubicin—testicular cancer	0.000367	0.000387	CcSEcCtD
Cevimeline—Haemorrhage—Doxorubicin—testicular cancer	0.000366	0.000386	CcSEcCtD
Cevimeline—Hypoaesthesia—Doxorubicin—testicular cancer	0.000364	0.000384	CcSEcCtD
Cevimeline—Pharyngitis—Doxorubicin—testicular cancer	0.000363	0.000383	CcSEcCtD
Cevimeline—Oedema peripheral—Doxorubicin—testicular cancer	0.00036	0.000381	CcSEcCtD
Cevimeline—Dysgeusia—Methotrexate—testicular cancer	0.00036	0.00038	CcSEcCtD
Cevimeline—Asthenia—Etoposide—testicular cancer	0.000359	0.00038	CcSEcCtD
Cevimeline—Angiopathy—Epirubicin—testicular cancer	0.000359	0.000379	CcSEcCtD
Cevimeline—Urethral disorder—Doxorubicin—testicular cancer	0.000358	0.000379	CcSEcCtD
Cevimeline—Back pain—Methotrexate—testicular cancer	0.000356	0.000376	CcSEcCtD
Cevimeline—Chills—Epirubicin—testicular cancer	0.000355	0.000375	CcSEcCtD
Cevimeline—Pruritus—Etoposide—testicular cancer	0.000354	0.000374	CcSEcCtD
Cevimeline—Arrhythmia—Epirubicin—testicular cancer	0.000353	0.000373	CcSEcCtD
Cevimeline—Visual impairment—Doxorubicin—testicular cancer	0.000352	0.000372	CcSEcCtD
Cevimeline—Alopecia—Epirubicin—testicular cancer	0.000349	0.000369	CcSEcCtD
Cevimeline—Vomiting—Cisplatin—testicular cancer	0.000348	0.000367	CcSEcCtD
Cevimeline—Rash—Cisplatin—testicular cancer	0.000345	0.000364	CcSEcCtD
Cevimeline—Dermatitis—Cisplatin—testicular cancer	0.000344	0.000364	CcSEcCtD
Cevimeline—Malnutrition—Epirubicin—testicular cancer	0.000344	0.000363	CcSEcCtD
Cevimeline—Diarrhoea—Etoposide—testicular cancer	0.000343	0.000362	CcSEcCtD
Cevimeline—Eye disorder—Doxorubicin—testicular cancer	0.000342	0.000361	CcSEcCtD
Cevimeline—Ill-defined disorder—Methotrexate—testicular cancer	0.000341	0.00036	CcSEcCtD
Cevimeline—Tinnitus—Doxorubicin—testicular cancer	0.000341	0.00036	CcSEcCtD
Cevimeline—Anaemia—Methotrexate—testicular cancer	0.00034	0.000359	CcSEcCtD
Cevimeline—Flushing—Doxorubicin—testicular cancer	0.000339	0.000359	CcSEcCtD
Cevimeline—Cardiac disorder—Doxorubicin—testicular cancer	0.000339	0.000359	CcSEcCtD
Cevimeline—Flatulence—Epirubicin—testicular cancer	0.000339	0.000358	CcSEcCtD
Cevimeline—Dysgeusia—Epirubicin—testicular cancer	0.000337	0.000356	CcSEcCtD
Cevimeline—Back pain—Epirubicin—testicular cancer	0.000333	0.000352	CcSEcCtD
Cevimeline—Angiopathy—Doxorubicin—testicular cancer	0.000332	0.00035	CcSEcCtD
Cevimeline—Malaise—Methotrexate—testicular cancer	0.000332	0.00035	CcSEcCtD
Cevimeline—Dizziness—Etoposide—testicular cancer	0.000331	0.00035	CcSEcCtD
Cevimeline—Muscle spasms—Epirubicin—testicular cancer	0.000331	0.000349	CcSEcCtD
Cevimeline—Vertigo—Methotrexate—testicular cancer	0.00033	0.000349	CcSEcCtD
Cevimeline—Leukopenia—Methotrexate—testicular cancer	0.000329	0.000348	CcSEcCtD
Cevimeline—Chills—Doxorubicin—testicular cancer	0.000328	0.000347	CcSEcCtD
Cevimeline—Arrhythmia—Doxorubicin—testicular cancer	0.000327	0.000345	CcSEcCtD
Cevimeline—Nausea—Cisplatin—testicular cancer	0.000325	0.000343	CcSEcCtD
Cevimeline—Alopecia—Doxorubicin—testicular cancer	0.000323	0.000341	CcSEcCtD
Cevimeline—Cough—Methotrexate—testicular cancer	0.000321	0.000339	CcSEcCtD
Cevimeline—Ill-defined disorder—Epirubicin—testicular cancer	0.000319	0.000337	CcSEcCtD
Cevimeline—Convulsion—Methotrexate—testicular cancer	0.000319	0.000336	CcSEcCtD
Cevimeline—Vomiting—Etoposide—testicular cancer	0.000318	0.000336	CcSEcCtD
Cevimeline—Malnutrition—Doxorubicin—testicular cancer	0.000318	0.000336	CcSEcCtD
Cevimeline—Anaemia—Epirubicin—testicular cancer	0.000318	0.000336	CcSEcCtD
Cevimeline—Agitation—Epirubicin—testicular cancer	0.000316	0.000334	CcSEcCtD
Cevimeline—Rash—Etoposide—testicular cancer	0.000316	0.000334	CcSEcCtD
Cevimeline—Dermatitis—Etoposide—testicular cancer	0.000316	0.000333	CcSEcCtD
Cevimeline—Headache—Etoposide—testicular cancer	0.000314	0.000331	CcSEcCtD
Cevimeline—Flatulence—Doxorubicin—testicular cancer	0.000314	0.000331	CcSEcCtD
Cevimeline—Chest pain—Methotrexate—testicular cancer	0.000313	0.000331	CcSEcCtD
Cevimeline—Myalgia—Methotrexate—testicular cancer	0.000313	0.000331	CcSEcCtD
Cevimeline—Arthralgia—Methotrexate—testicular cancer	0.000313	0.000331	CcSEcCtD
Cevimeline—Dysgeusia—Doxorubicin—testicular cancer	0.000312	0.000329	CcSEcCtD
Cevimeline—Malaise—Epirubicin—testicular cancer	0.00031	0.000328	CcSEcCtD
Cevimeline—Discomfort—Methotrexate—testicular cancer	0.000309	0.000327	CcSEcCtD
Cevimeline—Vertigo—Epirubicin—testicular cancer	0.000309	0.000327	CcSEcCtD
Cevimeline—Syncope—Epirubicin—testicular cancer	0.000309	0.000326	CcSEcCtD
Cevimeline—Leukopenia—Epirubicin—testicular cancer	0.000308	0.000325	CcSEcCtD
Cevimeline—Back pain—Doxorubicin—testicular cancer	0.000308	0.000325	CcSEcCtD
Cevimeline—Muscle spasms—Doxorubicin—testicular cancer	0.000306	0.000323	CcSEcCtD
Cevimeline—Palpitations—Epirubicin—testicular cancer	0.000304	0.000321	CcSEcCtD
Cevimeline—Confusional state—Methotrexate—testicular cancer	0.000303	0.00032	CcSEcCtD
Cevimeline—Loss of consciousness—Epirubicin—testicular cancer	0.000302	0.000319	CcSEcCtD
Cevimeline—Cough—Epirubicin—testicular cancer	0.0003	0.000317	CcSEcCtD
Cevimeline—Convulsion—Epirubicin—testicular cancer	0.000298	0.000315	CcSEcCtD
Cevimeline—Infection—Methotrexate—testicular cancer	0.000298	0.000315	CcSEcCtD
Cevimeline—Nausea—Etoposide—testicular cancer	0.000298	0.000314	CcSEcCtD
Cevimeline—Hypertension—Epirubicin—testicular cancer	0.000297	0.000314	CcSEcCtD
Cevimeline—Ill-defined disorder—Doxorubicin—testicular cancer	0.000295	0.000312	CcSEcCtD
Cevimeline—Nervous system disorder—Methotrexate—testicular cancer	0.000294	0.000311	CcSEcCtD
Cevimeline—Anaemia—Doxorubicin—testicular cancer	0.000294	0.000311	CcSEcCtD
Cevimeline—Thrombocytopenia—Methotrexate—testicular cancer	0.000294	0.00031	CcSEcCtD
Cevimeline—Chest pain—Epirubicin—testicular cancer	0.000293	0.000309	CcSEcCtD
Cevimeline—Arthralgia—Epirubicin—testicular cancer	0.000293	0.000309	CcSEcCtD
Cevimeline—Myalgia—Epirubicin—testicular cancer	0.000293	0.000309	CcSEcCtD
Cevimeline—Agitation—Doxorubicin—testicular cancer	0.000293	0.000309	CcSEcCtD
Cevimeline—Anxiety—Epirubicin—testicular cancer	0.000292	0.000308	CcSEcCtD
Cevimeline—Skin disorder—Methotrexate—testicular cancer	0.000291	0.000308	CcSEcCtD
Cevimeline—Hyperhidrosis—Methotrexate—testicular cancer	0.00029	0.000306	CcSEcCtD
Cevimeline—Discomfort—Epirubicin—testicular cancer	0.000289	0.000306	CcSEcCtD
Cevimeline—Malaise—Doxorubicin—testicular cancer	0.000287	0.000303	CcSEcCtD
Cevimeline—Vertigo—Doxorubicin—testicular cancer	0.000286	0.000302	CcSEcCtD
Cevimeline—Anorexia—Methotrexate—testicular cancer	0.000286	0.000302	CcSEcCtD
Cevimeline—Syncope—Doxorubicin—testicular cancer	0.000285	0.000302	CcSEcCtD
Cevimeline—Leukopenia—Doxorubicin—testicular cancer	0.000285	0.000301	CcSEcCtD
Cevimeline—Confusional state—Epirubicin—testicular cancer	0.000283	0.000299	CcSEcCtD
Cevimeline—Palpitations—Doxorubicin—testicular cancer	0.000281	0.000297	CcSEcCtD
Cevimeline—Oedema—Epirubicin—testicular cancer	0.000281	0.000297	CcSEcCtD
Cevimeline—Hypotension—Methotrexate—testicular cancer	0.00028	0.000296	CcSEcCtD
Cevimeline—Loss of consciousness—Doxorubicin—testicular cancer	0.00028	0.000296	CcSEcCtD
Cevimeline—Infection—Epirubicin—testicular cancer	0.000279	0.000295	CcSEcCtD
Cevimeline—Cough—Doxorubicin—testicular cancer	0.000278	0.000293	CcSEcCtD
Cevimeline—Shock—Epirubicin—testicular cancer	0.000276	0.000292	CcSEcCtD
Cevimeline—Convulsion—Doxorubicin—testicular cancer	0.000276	0.000291	CcSEcCtD
Cevimeline—Nervous system disorder—Epirubicin—testicular cancer	0.000275	0.000291	CcSEcCtD
Cevimeline—Thrombocytopenia—Epirubicin—testicular cancer	0.000275	0.00029	CcSEcCtD
Cevimeline—Hypertension—Doxorubicin—testicular cancer	0.000275	0.00029	CcSEcCtD
Cevimeline—Tachycardia—Epirubicin—testicular cancer	0.000274	0.000289	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000273	0.000289	CcSEcCtD
Cevimeline—Skin disorder—Epirubicin—testicular cancer	0.000273	0.000288	CcSEcCtD
Cevimeline—Hyperhidrosis—Epirubicin—testicular cancer	0.000271	0.000287	CcSEcCtD
Cevimeline—Insomnia—Methotrexate—testicular cancer	0.000271	0.000287	CcSEcCtD
Cevimeline—Arthralgia—Doxorubicin—testicular cancer	0.000271	0.000286	CcSEcCtD
Cevimeline—Chest pain—Doxorubicin—testicular cancer	0.000271	0.000286	CcSEcCtD
Cevimeline—Myalgia—Doxorubicin—testicular cancer	0.000271	0.000286	CcSEcCtD
Cevimeline—Anxiety—Doxorubicin—testicular cancer	0.00027	0.000285	CcSEcCtD
Cevimeline—Paraesthesia—Methotrexate—testicular cancer	0.000269	0.000285	CcSEcCtD
Cevimeline—Discomfort—Doxorubicin—testicular cancer	0.000268	0.000283	CcSEcCtD
Cevimeline—Anorexia—Epirubicin—testicular cancer	0.000268	0.000283	CcSEcCtD
Cevimeline—Dyspnoea—Methotrexate—testicular cancer	0.000267	0.000283	CcSEcCtD
Cevimeline—Somnolence—Methotrexate—testicular cancer	0.000267	0.000282	CcSEcCtD
Cevimeline—Dyspepsia—Methotrexate—testicular cancer	0.000264	0.000279	CcSEcCtD
Cevimeline—Hypotension—Epirubicin—testicular cancer	0.000262	0.000277	CcSEcCtD
Cevimeline—Confusional state—Doxorubicin—testicular cancer	0.000262	0.000277	CcSEcCtD
Cevimeline—Decreased appetite—Methotrexate—testicular cancer	0.000261	0.000276	CcSEcCtD
Cevimeline—Oedema—Doxorubicin—testicular cancer	0.00026	0.000274	CcSEcCtD
Cevimeline—Fatigue—Methotrexate—testicular cancer	0.000259	0.000273	CcSEcCtD
Cevimeline—Infection—Doxorubicin—testicular cancer	0.000258	0.000273	CcSEcCtD
Cevimeline—Pain—Methotrexate—testicular cancer	0.000257	0.000271	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000256	0.00027	CcSEcCtD
Cevimeline—Shock—Doxorubicin—testicular cancer	0.000256	0.00027	CcSEcCtD
Cevimeline—Nervous system disorder—Doxorubicin—testicular cancer	0.000255	0.000269	CcSEcCtD
Cevimeline—Thrombocytopenia—Doxorubicin—testicular cancer	0.000254	0.000269	CcSEcCtD
Cevimeline—Insomnia—Epirubicin—testicular cancer	0.000254	0.000268	CcSEcCtD
Cevimeline—Tachycardia—Doxorubicin—testicular cancer	0.000254	0.000268	CcSEcCtD
Cevimeline—Skin disorder—Doxorubicin—testicular cancer	0.000252	0.000267	CcSEcCtD
Cevimeline—Paraesthesia—Epirubicin—testicular cancer	0.000252	0.000266	CcSEcCtD
Cevimeline—Hyperhidrosis—Doxorubicin—testicular cancer	0.000251	0.000265	CcSEcCtD
Cevimeline—Dyspnoea—Epirubicin—testicular cancer	0.00025	0.000264	CcSEcCtD
Cevimeline—Somnolence—Epirubicin—testicular cancer	0.00025	0.000264	CcSEcCtD
Cevimeline—Anorexia—Doxorubicin—testicular cancer	0.000248	0.000262	CcSEcCtD
Cevimeline—Feeling abnormal—Methotrexate—testicular cancer	0.000247	0.000261	CcSEcCtD
Cevimeline—Dyspepsia—Epirubicin—testicular cancer	0.000247	0.000261	CcSEcCtD
Cevimeline—Gastrointestinal pain—Methotrexate—testicular cancer	0.000245	0.000259	CcSEcCtD
Cevimeline—Decreased appetite—Epirubicin—testicular cancer	0.000244	0.000258	CcSEcCtD
Cevimeline—Hypotension—Doxorubicin—testicular cancer	0.000243	0.000256	CcSEcCtD
Cevimeline—Fatigue—Epirubicin—testicular cancer	0.000242	0.000256	CcSEcCtD
Cevimeline—Pain—Epirubicin—testicular cancer	0.00024	0.000254	CcSEcCtD
Cevimeline—Constipation—Epirubicin—testicular cancer	0.00024	0.000254	CcSEcCtD
Cevimeline—Urticaria—Methotrexate—testicular cancer	0.000238	0.000252	CcSEcCtD
Cevimeline—Body temperature increased—Methotrexate—testicular cancer	0.000237	0.000251	CcSEcCtD
Cevimeline—Abdominal pain—Methotrexate—testicular cancer	0.000237	0.000251	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000237	0.00025	CcSEcCtD
Cevimeline—Insomnia—Doxorubicin—testicular cancer	0.000235	0.000248	CcSEcCtD
Cevimeline—Paraesthesia—Doxorubicin—testicular cancer	0.000233	0.000246	CcSEcCtD
Cevimeline—Dyspnoea—Doxorubicin—testicular cancer	0.000232	0.000245	CcSEcCtD
Cevimeline—Feeling abnormal—Epirubicin—testicular cancer	0.000231	0.000244	CcSEcCtD
Cevimeline—Somnolence—Doxorubicin—testicular cancer	0.000231	0.000244	CcSEcCtD
Cevimeline—Gastrointestinal pain—Epirubicin—testicular cancer	0.00023	0.000243	CcSEcCtD
Cevimeline—Dyspepsia—Doxorubicin—testicular cancer	0.000229	0.000242	CcSEcCtD
Cevimeline—Decreased appetite—Doxorubicin—testicular cancer	0.000226	0.000239	CcSEcCtD
Cevimeline—Fatigue—Doxorubicin—testicular cancer	0.000224	0.000237	CcSEcCtD
Cevimeline—Urticaria—Epirubicin—testicular cancer	0.000223	0.000236	CcSEcCtD
Cevimeline—Pain—Doxorubicin—testicular cancer	0.000222	0.000235	CcSEcCtD
Cevimeline—Constipation—Doxorubicin—testicular cancer	0.000222	0.000235	CcSEcCtD
Cevimeline—Abdominal pain—Epirubicin—testicular cancer	0.000222	0.000234	CcSEcCtD
Cevimeline—Body temperature increased—Epirubicin—testicular cancer	0.000222	0.000234	CcSEcCtD
Cevimeline—Hypersensitivity—Methotrexate—testicular cancer	0.000221	0.000234	CcSEcCtD
Cevimeline—Asthenia—Methotrexate—testicular cancer	0.000215	0.000227	CcSEcCtD
Cevimeline—Feeling abnormal—Doxorubicin—testicular cancer	0.000214	0.000226	CcSEcCtD
Cevimeline—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000212	0.000224	CcSEcCtD
Cevimeline—Pruritus—Methotrexate—testicular cancer	0.000212	0.000224	CcSEcCtD
Cevimeline—Hypersensitivity—Epirubicin—testicular cancer	0.000207	0.000219	CcSEcCtD
Cevimeline—Urticaria—Doxorubicin—testicular cancer	0.000206	0.000218	CcSEcCtD
Cevimeline—Body temperature increased—Doxorubicin—testicular cancer	0.000205	0.000217	CcSEcCtD
Cevimeline—Abdominal pain—Doxorubicin—testicular cancer	0.000205	0.000217	CcSEcCtD
Cevimeline—Diarrhoea—Methotrexate—testicular cancer	0.000205	0.000217	CcSEcCtD
Cevimeline—Asthenia—Epirubicin—testicular cancer	0.000201	0.000213	CcSEcCtD
Cevimeline—Pruritus—Epirubicin—testicular cancer	0.000199	0.00021	CcSEcCtD
Cevimeline—Dizziness—Methotrexate—testicular cancer	0.000198	0.00021	CcSEcCtD
Cevimeline—Diarrhoea—Epirubicin—testicular cancer	0.000192	0.000203	CcSEcCtD
Cevimeline—Hypersensitivity—Doxorubicin—testicular cancer	0.000191	0.000202	CcSEcCtD
Cevimeline—Vomiting—Methotrexate—testicular cancer	0.000191	0.000202	CcSEcCtD
Cevimeline—Rash—Methotrexate—testicular cancer	0.000189	0.0002	CcSEcCtD
Cevimeline—Dermatitis—Methotrexate—testicular cancer	0.000189	0.0002	CcSEcCtD
Cevimeline—Headache—Methotrexate—testicular cancer	0.000188	0.000199	CcSEcCtD
Cevimeline—Asthenia—Doxorubicin—testicular cancer	0.000186	0.000197	CcSEcCtD
Cevimeline—Dizziness—Epirubicin—testicular cancer	0.000186	0.000196	CcSEcCtD
Cevimeline—Pruritus—Doxorubicin—testicular cancer	0.000184	0.000194	CcSEcCtD
Cevimeline—Vomiting—Epirubicin—testicular cancer	0.000179	0.000189	CcSEcCtD
Cevimeline—Nausea—Methotrexate—testicular cancer	0.000178	0.000188	CcSEcCtD
Cevimeline—Diarrhoea—Doxorubicin—testicular cancer	0.000178	0.000188	CcSEcCtD
Cevimeline—Rash—Epirubicin—testicular cancer	0.000177	0.000187	CcSEcCtD
Cevimeline—Dermatitis—Epirubicin—testicular cancer	0.000177	0.000187	CcSEcCtD
Cevimeline—Headache—Epirubicin—testicular cancer	0.000176	0.000186	CcSEcCtD
Cevimeline—Dizziness—Doxorubicin—testicular cancer	0.000172	0.000181	CcSEcCtD
Cevimeline—Nausea—Epirubicin—testicular cancer	0.000167	0.000176	CcSEcCtD
Cevimeline—Vomiting—Doxorubicin—testicular cancer	0.000165	0.000175	CcSEcCtD
Cevimeline—Rash—Doxorubicin—testicular cancer	0.000164	0.000173	CcSEcCtD
Cevimeline—Dermatitis—Doxorubicin—testicular cancer	0.000164	0.000173	CcSEcCtD
Cevimeline—Headache—Doxorubicin—testicular cancer	0.000163	0.000172	CcSEcCtD
Cevimeline—Nausea—Doxorubicin—testicular cancer	0.000154	0.000163	CcSEcCtD
